UNSPSC 51333107: Carvotroline hydrochloride

This classification denotes an antipsychotic agent C18H18FN3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OGU53DND3M, chemically known as 1h-pyrido(4,3-b)indole, 8-fluoro-2,3,4,5-tetrahydro-2-(2-(4-pyridinyl)ethyl)-, monohydrochloride, but more generally known as carvotroline hydrochloride, which bears US NIH Compound Identifier 72037. Most nations, for tariff and trade purposes, schedule carvotroline hydrochloride under HS 29333999 and SITC 51574.

As of Q4 2014, CARVOTROLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CC2C(CC1F)C3C([NH]2)CCN(C3)CCC4CCNCC4.CL.

UNSPSC 51333107 Carvotroline hydrochloride is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local procurement activity under this code shows a mismatch: Seminole County, Florida posted an IFB for naloxone and safe drug deactivation systems, neither of which is carvotroline hydrochloride. The county solicitation targets community health initiatives, with quarterly deliveries required to support the Seminole County Community Health Building in Sanford, Florida. Bidders must provide unit pricing, comply with drug-free workplace and E-Verify requirements, maintain workers' compensation and commercial general liability insurance, and accept a three-month probationary period during which the county may terminate without cause. The contract is potentially FEMA-funded, which introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations.

The code shows minimal recent relevant activity — the single posted opportunity (IFB 60459723LAS, due July 26, 2023) does not align with carvotroline hydrochloride procurement. Seminole County is the only issuing body represented in the recent record. The geographic scope is limited to Seminole County, Florida. Business development professionals should treat this code as inactive for state and local procurement purposes under its nominal definition; the mismatch between the code assignment and actual solicitation content suggests either a classification error in the source or that carvotroline hydrochloride rarely appears in state and local health-system purchasing workflows.